Orbimed Advisors LLC Bristol Myers Squibb CO Call Options Transaction History

Orbimed Advisors LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2019 Nov 14, 2019	SELL	$42.77 - $50.71 $21.4 Million - $25.4 Million	-500,000 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$44.62 - $49.34 $13.4 Million - $14.8 Million	300,000 Added 150.0%	500,000 $22.7 Million
Q1 2018 May 15, 2018	BUY	$59.92 - $68.98 $3 Million - $3.45 Million	50,000 Added 33.33%	200,000 $12.7 Million
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $8.28 Million - $9.56 Million	150,000	150,000 $9.56 Million

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $124B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Orbimed Advisors LLC with notifications on news.